Cargando…
Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
(149)Tb represents a powerful alternative to currently used α-emitters: the relatively short half-life (T(1/2) = 4.1 h), low α-energy (3.97 MeV, I(α) = 16.7 %), absence of α-emitting daughters and stable coordination via DOTA are favorable features for potential clinical application. In this letter,...
Autores principales: | Müller, Cristina, Vermeulen, Christiaan, Köster, Ulli, Johnston, Karl, Türler, Andreas, Schibli, Roger, van der Meulen, Nicholas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843804/ https://www.ncbi.nlm.nih.gov/pubmed/29564382 http://dx.doi.org/10.1186/s41181-016-0008-2 |
Ejemplares similares
-
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014) -
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014) -
Terbium-149 for targeted alpha therapy
por: Borgna, Francesca, et al.
Publicado: (2021) -
Terbium-149 for targeted alpha therapy
por: Grundler, Pascal, et al.
Publicado: (2023) -
(47)Sc as useful β(–)-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes
por: Domnanich, Katharina A., et al.
Publicado: (2017)